Joint Formulary & PAD

Esketamine hydrochloride - Depression

I agree that in using this database I understand that this platform only provides guidance on local prescribing policy and that all prescribing decisions are ultimately the responsibility of the clinician.

Status 1

Non Formulary
Formulations :
  • Not Specified
Associated Icons :
Restrictions / Comments :
Important
Subject to NICE TA854

Documentation

  • No records returned.

PAD Profile

ChemicalSubstance :
Esketamine hydrochloride
Indication :
Depression
Group Name :
Keywords :
Treatment resistant
Brand Names Include :
Spravato
Important Information :
Latest Additions Date From :
Latest Additions Date To :
Guidelines :
Supporting Documents :
0

Other Indications

Below are listed other indications that Esketamine hydrochloride is used to treat.

  • No records returned.

Other Drugs

Below are listed other drugs that are used to treat Depression.

Committee Recommendations (1)

The Surrey Heartlands Integrated Care System Area Prescribing Committee (APC) has confirmed a NON-FORMULARY traffic light status for esketamine for treating major depressive disorder in adults at imminent risk of suicide.

This decision is in view of the NICE terminated Technology Appraisal for esketamine for this indication